吗替麦考酚酯

pro_cas
115007-34-6 ;124832-27-5 ;128794-94-5
pro_cdbregno
CCD00176107
pro_formula
C23 H31 N O7
pro_molWeight
433.498

basic_info

Product_Name: 吗替麦考酚酯
CAS: 115007-34-6 ;124832-27-5 ;128794-94-5
中文同义词: 2-(4-吗啉基)乙基 (E)-6-(4-羟基-6-甲氧基-7-甲基-3-氧代-1,3-二氢异苯并呋喃-5-基)-4-甲基己-4-烯酸酯 ; 霉酚酸吗啉乙酯 ; 霉酚酸酯 ; 吗替麦考酚酯
EnglishSynonyms: MYCOPHENOLATE MOFETIL, 98.0%~102% ; (4E)-6-(1,3-DIHYDRO-4-HYDROXY-6-METHOXY-7-METHYL-3-OXO-5-ISOBENZOFURANYL)4-HEXENOIC ACID 4-METHYL-2-(4-MORPHOLINYL)ETHYL ESTER ; (4E)-6-(1,3-DIHYDRO-4-HYDROXY-6-METHOXY-7-METHYL-3-OXO-5-ISOBENZOFURANYL)-4-METHYL-4-HEXENOIC ACID 2-(4-MORPHOLINYL)ETHYL ESTER ; MYCOPHENOLIC ACID 2-(4-MORPHOLINYL)ETHYL ESTER ; (E)-2-MORPHOLINOETHYL 6-(4-HYDROXY-6-METHOXY-7-METHYL-3-OXO-1,3-DIHYDROISOBENZOFURAN-5-YL)-4-METHYLHEX-4-ENOATE ; 2-MORPHOLINOETHYL (E)-6-(4-HYDROXY-6-METHOXY-7-METHYL-3-OXO-5-PHTHALANYL)-4-METHYL-4-HEXENOATE ; CELLCEPT ; TM-MMF ; VALACYCLOVIR (HYDROCHLORIDE) ; 4-HEXENOIC ACID, 6-(1,3-DIHYDRO-4-HYDROXY-6-METHOXY-7-METHYL-3-OXO-5-ISOBENZOFURANYL)-4-METHYL-, 2-(4-MORPHOLINYL)ETHYL ESTER ; 6-[(7-HYDROXY-5-METHOXY-4-METHYL-1-OXO-3H-ISOBENZOFURAN-6-YL)]-4-METHYL-HEX-4-ENOIC ACID 2-MORPHOLINOETHYL ESTER ; MYCOPHENOLATE MOFETIL
pro_mdlNumber: MFCD00867568
pro_acceptors: 8
pro_donors: 1
pro_smile: Cc1c2c(c(c(c1OC)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)O)C(=O)OC2
InChi: InChI=1S/C23H31NO7/c1-15(5-7-19(25)30-13-10-24-8-11-29-12-9-24)4-6-17-21(26)20-18(14-31-23(20)27)16(2)22(17)28-3/h4,26H,5-14H2,1-3H3/b15-4+
InChiKey: InChIKey=RTGDFNSFWBGLEC-SYZQJQIISA-N

property

Comments: BIOCHEM/PHYSIOL ACTIONS: MYCOPHENOLATE MOFETIL IS A PRODRUG OF MYCOPHENOLIC ACID (CAT NO M5255) THAT IS CLEAVED BY NONSPECIFIC ESTERASES IN VIVO TO PRODUCE THE PARENT COMPOUND. MYCOPHENOLIC ACID BLOCKS INOSINE MONOPHOSPHATE DEHYDROGENASE AND IS A POTENT IMMUNOSUPPRESIVE AGENT
FOR PEAK IDENTIFICATION
GENERAL DESCRIPTION: THIS PRODUCT IS PROVIDED AS DELIVERED AND SPECIFIED BY THE ISSUING PHARMACOPOEIA. ALL INFORMATION PROVIDED IN SUPPORT OF THIS PRODUCT, INCLUDING MSDS AND ANY PRODUCT INFORMATION LEAFLETS HAVE BEEN DEVELOPED AND ISSUED UNDER THE AUTHORITY OF THE ISSUING PHARMACOPOEIA. FOR FURTHER INFORMATION AND SUPPORT PLEASE GO TO THE WEBSITE OF THE ISSUING PHARMACOPOEIA
OTHER NOTES: SALES RESTRICTIONS MAY APPLY

secure_info

* If the product has intellectual property rights, a license granted is must or contact us.